Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16716759 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis
Condition: Moderately Active Ulcerative Colitis
Interventions: Biological: AG011;   Other: Placebo

Indicates status has not been verified in more than two years